First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
The company showcased three core programs developed through this platform
Extended lab space for product development, customer demos, and training
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
Subscribe To Our Newsletter & Stay Updated
